Electromagnetic Field Protection Device Use Impact in Healthy Volunteers

TruDiagnostic

Status and phase: Unknown; Phase 2

Conditions: Aging; Aging Well

Treatments: Device: In-home resonance-based electromagnetic field protection device

Study type: Interventional

Funder types: Industry; Other

Identifiers

NCT05001646

ALT-BS-001

Details and patient eligibility

About

This is a prospective, single group, self-controlled study to evaluate the clinical and molecular impact of continuous in-home resonance-based electromagnetic field (EMF) protection device usage in healthy individuals.

Enrollment: 44 estimated patients

Sex: All

Ages: 30 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Any sex, gender orientation, and ethnicity
• Between ages 30 and 70
• Must be willing and able to participate in venipuncture, health history and clinical assessments, passive monitoring (Oura ring), and continuous in-home Blushield device usage

Exclusion criteria

• Significant change in diagnosis and/or treatment of major illness or injury within 2 years prior to screening, e.g., diabetes, cancer, cardiovascular disease, psychiatric condition 2. Any ongoing immune system concerns or immunodeficiency disease
• History of any viral illness in preceding year
• Body mass index (BMI) > 35 kg/m2
• Presence of active infection
• Any other illness, disorder, alcohol or chemical dependence that in the opinion of investigators would render study participation unsuitable
• Unable or unwilling to provide required biological sample
• Unable or unwilling to avoid pregnancy during study period

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

44 participants in 1 patient group

In-home EMF protection device

Experimental group

Treatment:

Device: In-home resonance-based electromagnetic field protection device